Product
KYV101
1 clinical trial
1 indication
Indication
Rheumatoid ArthritisClinical trial
Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis. Two-stage Interventional, Prospective, Randomized, Controlled, Open Label, Parallel-group Phase I/II Trial in Patients With Active, ACPA-positive and Treatment Refractory Rheumatoid ArthritisStatus: Not yet recruiting, Estimated PCD: 2027-03-01